← All news

FROM THE NEWS FEED

Compass Pathways to Participate in TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026

2026-09-16 β€’ Psychedelic Invest

Article summary

LONDON & NEW YORK, September 16, 2026--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today…

Continue to the original publication for the complete article.